Insmed, Inc. (INSM)
121.78
-2.20
(-1.77%)
USD |
NASDAQ |
Sep 18, 14:17
Insmed 30-Day Average Daily Volume : 2.394M for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 2.394M |
| September 16, 2026 | 2.504M |
| September 15, 2026 | 2.599M |
| September 14, 2026 | 2.606M |
| September 11, 2026 | 2.649M |
| September 10, 2026 | 2.704M |
| September 09, 2026 | 2.691M |
| September 08, 2026 | 2.661M |
| September 04, 2026 | 2.671M |
| September 03, 2026 | 2.674M |
| September 02, 2026 | 2.670M |
| September 01, 2026 | 2.662M |
| August 31, 2026 | 2.697M |
| August 28, 2026 | 2.684M |
| August 27, 2026 | 2.685M |
| August 26, 2026 | 2.742M |
| August 25, 2026 | 2.746M |
| August 24, 2026 | 2.729M |
| August 21, 2026 | 2.778M |
| August 20, 2026 | 2.838M |
| August 19, 2026 | 2.885M |
| August 18, 2026 | 2.930M |
| August 17, 2026 | 2.943M |
| August 14, 2026 | 2.954M |
| August 13, 2026 | 2.981M |
| Date | Value |
|---|---|
| August 12, 2026 | 2.979M |
| August 11, 2026 | 3.039M |
| August 10, 2026 | 3.039M |
| August 07, 2026 | 3.127M |
| August 06, 2026 | 3.111M |
| August 05, 2026 | 2.814M |
| August 04, 2026 | 2.791M |
| August 03, 2026 | 2.790M |
| July 31, 2026 | 3.451M |
| July 30, 2026 | 3.470M |
| July 29, 2026 | 3.472M |
| July 28, 2026 | 3.525M |
| July 27, 2026 | 3.611M |
| July 24, 2026 | 3.718M |
| July 23, 2026 | 3.835M |
| July 22, 2026 | 3.918M |
| July 21, 2026 | 4.026M |
| July 20, 2026 | 4.210M |
| July 17, 2026 | 4.204M |
| July 16, 2026 | 4.237M |
| July 15, 2026 | 4.225M |
| July 14, 2026 | 4.266M |
| July 13, 2026 | 4.356M |
| July 10, 2026 | 4.336M |
| July 09, 2026 | 4.342M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.496M |
| Biogen, Inc. | 739073.4 |
| Gilead Sciences, Inc. | 5.607M |
| Agios Pharmaceuticals, Inc. | 926773.8 |
| Arcutis Biotherapeutics, Inc. | 2.180M |